Takeda

ELAPRASE

Manufacturer:

Takeda

Elaprase HCPCS:

J1743

HCPCS Code Descriptor:

Injection, idursulfase, 1 mg

Category:

J Code

Elaprase NDCs:

54092-0700-01

Primary Type:

Enzyme Replacement Therapy

Generic/Specialty Status:

Single-Source

Package Type:

Vial

Route of Administration:

Intravenous

Elaprase CPT Codes:

Potential CPT administration codes for Elaprase can be found at the following link.

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Elaprase:

ELAPRASE is an Enzyme Replacement Therapy drug manufactured by Takeda and administered via the Intravenous route of administration. The J Code: J1743 is aligned to the drug ELAPRASE.

ACCESS PRICING AND MORE BY REGISTERING

J1743 Added Date:

January 1, 2008

J1743 Effective Date:

January 1, 2008

J1743 Termination Date:

HCPCS Active

Elaprase billing and coding information can be found through Takeda at the link below:
Elaprase patient assistance information can be found through OnePath Patient Support at the URL: https://www.elaprase.com/getting-started-support/onepath/
ELAPRASE prescribing information can be found at the link below:
Our team has not yet identified a source of side effects information for ELAPRASE. Please check back in a few weeks.